Cargando…
Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
Autor principal: | Hazlewood, Glen S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691927/ https://www.ncbi.nlm.nih.gov/pubmed/37531287 http://dx.doi.org/10.1093/rheumatology/kead388 |
Ejemplares similares
-
Procedural Volumes in the Era of COVID: The Risk Versus Benefit Trade-Off
por: Khandkar, Chinmay, et al.
Publicado: (2021) -
The risk-benefit trade-off in local excision of early rectal cancer
por: Kim, Chang Hyun
Publicado: (2022) -
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
por: Kerrigan, S. A., et al.
Publicado: (2018) -
Statins: benefits and risks revisited
por: Balaz, Miroslav, et al.
Publicado: (2019) -
Revisiting Trade-offs
between Rubisco Kinetic Parameters
por: Flamholz, Avi I., et al.
Publicado: (2019)